Major reviewAge-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies☆
Section snippets
DRUSEN
The clinical hallmark of AMD is the appearance of drusen,144 localized deposits lying between the basement membrane of the retinal pigment epithelium (RPE) and Bruch's membrane. In the earliest stage, they may be visible ophthalmoscopically as semi-translucent punctate dots in retroillumination. As the overlying RPE thins, drusen are more obvious as yellow-white deposits; they may regress, leaving atrophy in their wake. Clinically, drusen are classified morphologically either as hard or soft.
Pathology
AMD is a degenerative disease that affects the outer neural retina, RPE, Bruch's membrane, and the choroid. The locus of the primary insult remains in dispute. The hallmarks of the disease are diffuse and focal thickening of Bruch's membrane (drusen) together with the development of hypo- and hyper-pigmented areas of RPE, the former signifying areas of RPE cell loss.154., 155., 156.
Risk Factors and Relation to Etiology
Vast epidemiological studies have shed light on various factors associated with an altered risk of AMD. Apart from aiding early detection and treatment, these risk factors may also provide insight into the etiology of the disease. Table 2 provides a list on ongoing experimental trials for AMD.
Animal Models
There are no animal models that faithfully replicate all features of clinical AMD. This, in large part, has hampered the delineation of etiology and the development of a desirable prophylactic or curative treatment. However, spontaneous and iatrogenic conditions have shed some light.
GENETICS
Much evidence points to a familial component of AMD. Twin-concordance, linkage studies, and biomolecular investigations implicating genetic factors are compelling. Genetic analyses of AMD have been hindered by the late onset of the disease, which results in limited study pedigrees, as well as the intertwined nature of multiple genetic influences acting in concert with myriad environmental provocations. Furthermore, the clinical classification of AMD may not lend itself to genetic analyses:
Therapeutic Prospects
Although an array of risk factors has been epidemiologically related to AMD, their role in the progression of the disease remains equivocal. Recent studies have helped unravel some of the molecular processes involved, but their intricate interplay and complexity make the understanding of AMD still quite elusive. Still, with a greater understanding of the etiology of AMD have come therapeutic strategies that have moved beyond the limited approach of thermal laser photocoagulation. Photodynamic
Challenges
AMD promises to remain a major threat to vision for decades to come. Current management options represent a modest advance, but do not greatly alter the unrelenting course and prognosis of the disease itself. New advances in the understanding of the molecular mechanisms underpinning photoreceptor apoptosis, geographic atrophy, CNV, and disciform scarring hopefully will unlock the door to more targeted and effective therapeutic modalities. There are several milestones that must be achieved on
Method of Literature Search
References for this review were generated by a comprehensive literature search of the electronic PubMed database (1966–2003) and of the Association for Research in Vision and Ophthalmology abstracts (1996–2002). Additional articles, unavailable on electronic archives, were selected from a review of the bibliographies of the articles generated from the above search. The literature search was not limited to the English language; foreign language publications were translated to English. To ensure
References (523)
- et al.
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
Am J Ophthalmol
(1994) - et al.
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells
Biochem Biophys Res Commun
(1993) Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium
Am J Hum Genet
(2000)- et al.
Transscleral drug delivery to the retina and choroid
Prog Retin Eye Res
(2002) - et al.
A role for local inflammation in the formation of drusen in the aging eye
Am J Ophthalmol
(2002) - et al.
Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation
Am J Ophthalmol
(2001) - et al.
Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22
Genomics
(1994) - et al.
Indocyanine green angiography of drusen
Am J Ophthalmol
(1997) - et al.
Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells
Exp Eye Res
(1999) - et al.
The role of oxidative stress in the pathogenesis of age-related macular degeneration
Surv Ophthalmol
(2000)
Overexpression of fetal human pigment epithelium-derived factor in Escherichia coli. A functionally active neurotrophic factor
J Biol Chem
Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation
Am J Pathol
Risk factors in age-related maculopathy complicated by choroidal neovascularization
Ophthalmology
Light damage in the rat retina: the effect of dietary deprivation of N-3 fatty acids on acute structural alterations
Exp Eye Res
Cultured human retinal pigment epithelial cells differentially express thrombospondin-1, -2, -3, and -4
Int J Biochem Cell Biol
Randomized trial of radiation for age-related macular degeneration
Am J Ophthalmol
Prospective study of dietary fat and the risk of age-related macular degeneration
Am J Clin Nutr
Prospective study of zinc intake and the risk of age-related macular degeneration
Ann Epidemiol
The pathogenesis of tears of the retinal pigment epithelium
Am J Ophthalmol
Hyperzincuria in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high-dose zinc supplementation
Metabolism
Sun exposure and age-related macular degeneration. An Australian case-control study
Ophthalmology
Photocytotoxicity of lipofuscin in human retinal pigment epithelial cells
Free Radic Biol Med
Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration
Ophthalmology
High-dose supplements for age-related macular degeneration: Did you leave out Centrum?
Arch Ophthalmol
Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers
Int J Oncol
Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate
Arch Ophthalmol
Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-related eye disease study report number 3
Ophthalmology
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
Arch Ophthalmol
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
Proc Natl Acad Sci USA
Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration
Arch Ophthalmol
Macular translocation with retinotomy and retinal rotation for exudative age-related macular degeneration
Retina
The effect of the retinal circulation on vitreal oxygen tension
Curr Eye Res
Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization
Graefes Arch Clin Exp Ophthalmol
Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy
Graefes Arch Clin Exp Ophthalmol
Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies
Hum Genet
Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration
Science
A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy
Nat Genet
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
Nat Med
Cyclic AMP elevating agents and nitric oxide modulate angiotensin II-induced leukocyte-endothelial cell interactions in vivo
Br J Pharmacol
Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo
J Leukoc Biol
Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization
Invest Ophthalmol Vis Sci
Age-related eye disease study caveats
Arch Ophthalmol
Diffusion of high molecular weight compounds through sclera
Invest Ophthalmol Vis Sci
Transscleral delivery of bioactive protein to the choroid and retina
Invest Ophthalmol Vis Sci
Growth factor localization in choroidal neovascular membranes of age-related macular degeneration
Invest Ophthalmol Vis Sci
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3
Invest Ophthalmol Vis Sci
Nitric oxide is proangiogenic in the retina and choroid
J Cell Physiol
A treatment trial for geographic atrophy from AMD: The GAARD Study
Invest Ophthalmol Vis Sci
Reticular pseudodrusen. A risk factor in age-related maculopathy
Retina
Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor
Invest Ophthalmol Vis Sci
Cited by (849)
The structure and function of the human choroid
2024, Annals of AnatomyNanocarriers: the enhanced potential treatment of age-related macular degeneration
2023, Nanotechnology Principles in Drug Targeting and DiagnosisToward structural-omics of the bovine retinal pigment epithelium
2022, Cell Reports
- ☆
Supported, in part, by a Foundation Fighting Blindness Career Development Award (JA), Heed Ophthalmic Foundation (JA, BKA), AOS-Knapp Testimonial Fund (JA), University of Kentucky Physician Scientist Award (JA), Prevent Blindness America/Fight for Sight Grant-in-Aid (JA), National Eye Institute (APA), Massachusetts Lions Research Fund (APA), Falk Foundation (APA), Iaccoca Foundation (APA), and the Roberta Siegel Fund (APA). The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.